Long-term glucocorticoid treatment in patients with polymyalgia rheumatica: can we just move a step forward? Comments on “Long-term glucocorticoid treatment and high relapse rate remain unresolved issues in the real-life management of polymyalgia rheumatica: a systematic literature review and meta-analysis”-Reference-Cited by-同舟云学术

Long-term glucocorticoid treatment in patients with polymyalgia rheumatica: can we just move a step forward? Comments on “Long-term glucocorticoid treatment and high relapse rate remain unresolved issues in the real-life management of polymyalgia rheumatica: a systematic literature review and meta-analysis”

Published:2021-08-30 Issue:10 Volume:40 Page:4367-4368
ISSN:0770-3198
Container-title:Clinical Rheumatology
language:en
Short-container-title:Clin Rheumatol

Author:

Manzo Ciro^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Rheumatology

Link

https://link.springer.com/content/pdf/10.1007/s10067-021-05898-y.pdf

Reference9 articles.

1. Floris A, Piga M, Chessa E et al (2021) Long-term glucocorticoid treatment and high relapse rate remain unresolved issues in the real-life management of polymyalgia rheumatica: a systematic literature review and meta-analysis. Clin Rheumatol. https://doi.org/10.1007/s10067-021-05819-z

2. Manzo C, Milchert M, Natale M, Brzosko M (2019) Polymyalgia rheumatica with normal values of both erythrocyte sedimentation rate and C-reactive protein concentration at the time of diagnosis. Rheumatology (Oxford) 58:921–923. https://doi.org/10.1093/rheumatology/key431

3. Marsman DE, Den Broeder N, Boers N et al (2021) Polymyalgia rheumatica patients with and without elevated baseline acute phase reactants: distinct subgroups of polymyalgia rheumatica? Clin Exp Rheumatol 39:32–37

4. Manzo C (2021) C-reactive protein concentrations as predictors of glucocorticoid-free remission in patients with polymyalgia rheumatica. Int J Rheum Dis 24:284–285. https://doi.org/10.1111/1756-185X.14054

5. Cimmino MA, Parodi M, Montecucco C, Caporali R (2011) The correct prednisone starting dose in polymyalgia rheumatica is related to body weight but not to disease severity. BMC Musculoskelet Disord 12:94. https://doi.org/10.1186/1471-2474-12-94

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Tumor Necrosis Factor Alpha Antagonists (Anti TNF-α) in Personalized Treatment of Patients with Isolated Polymyalgia Rheumatica (PMR): Past and Possible Future Scenarios;Journal of Personalized Medicine;2022-02-22